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Results (Figs. 2,3):  
After 10 years, in 56/62 (90%) individ-
uals of Group A, mean CGI difference 
between diagnosis and last follow-up 
was 11 points (56%): 19 (range 15-25) 
vs. 8 (2-17) points. Actually, 9 (14%) 
patients each have homeopathic or 
methylphenidate (MPH) treatment, 2/11 
patients (11%) with primary stimulant 
medication have still MPH treatment. In 
38 (62%) individuals, treatment is 
finished. – In 35/39 individuals (90%) of 
groups B-D, the respective mean CGI 
difference was 11 points, too: 20 (range 
14-28) vs. 9 (1-19) points (group B: 
61%, groups C and D: 53% each). With 
MPH treatment (n=22, 63%), 18 patients 
(82%), with individual homeopathy 
(n=29, 83%) improved 17 patients (59%) 
more than 50% in CGI score; 7 of these 
patients each were treated with both 
therapies. In 23/35 individuals (60%), 
treatment is finished, 12 patients are 
still on medication: 9 with MPH, 2 with 
homeopathy and 1 patient with both 
therapies. In three patients each with 
MPH or homeopathic treatment, 
medicaments were not successful 
enough, one patient has to take 
antidepressants. Three patients each 
had and still have MPH medicines with 
improvement of 40%. – In concordance 
with CGI values, 25/35 probands (80%) 
rated their condition as better. Seven 
(7) probands rated themselves as 
equal, despite actual CGI values higher 
than 14 points and CGI difference to 
base line values is more than 9 (10-14) 
points, indicating approximately 50% 
improvement.  
 
Conclusion  
Individual homeopathic therapy seems 
to have similar results compared to  
MPH therapy, and avoids adverse 
events of stimulant therapies. Subject-
ive symptoms‘ perception is different 
from external evaluation in 20% of 
patients. In 23 young adults (66%), 
treatment is finished successfully. 
Background 
In neuropsychiatry, attention deficit hyper- 
activity disorder without or with hyper-
activity (ADD/ADHD) is one of the most 
prevalent diagnosis in childhood and 
adolescence. Stimulant medication is  
the preferred option in multimodal therap-  
eutic regimen. Twenty-five percent drop-
outs due to adverse events call for alter-  
native therapeutic modalities1. 
 
Aim 
Long-term follow-up (10 years) assess- 
ment of different therapeutic approaches in  
children and adolescents with ADD/ADHD.  
 
Method  
Thirty-nine (39) patients not included in  
the cross-over phase of the Bern ADHD  
study (Group A, n=622,) were classified  
into three diagnostic and therapeutic  
groups: (B) ADD/ADHD diagnosis and  
individual homeopathic treatment with  
Conners‘ Global Index (CGI) improvement  
> 50% (n=12), (C) ADD/ADHD diagnosis  
and homeopathic treatment with CGI 
improvement < 50% (n=13), (D) not all 
ADD/ADHD criteria fulfilled according to 
DSM-IV3 and various treatments (n=14). 
Clinical results were monitored with 
Conners’ Global Index Questionnaire
(CGI), and open questions of a self-
designed questionnaire or telephone 
interviews. They are analyzed by descrip-
tive methods. 
 
Recruitment, Group Allocation (Fig.1) 
140 families took interest due to lectures 
 39 kids don‘t fulfill AD(H)D dx at all 
 14 don’t fulfill all of DSM3 criteria (grp D)   
 87 fulfill ADD/ADHD criteria completely  
   4 pilot study participants (part of grp B)  
 13 with CGI improvement < 50% (grp C) 
 70 (84%) with CGI improvement > 50% 
   5 refuse RCT participation (part of grp B) 
    3 fulfill RCT criteria too late (part of  B) 
  62 begin, 58 finish RCT; 4 drop-outs2 
  56 with 10-years follow-up (6 drop-outs)4  
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Fig. 3  
CGI development (Groups B-D) before  treatment  
start  and during  follow-up 
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Fig. 1 
Recruitment, patient flow and group B-D allocation 
(marked in red,  adapted from2) 
Fig.  2 
CGI development (Group A) before treatment  start  
and during  follow-up 
 
  
 
	  
	   140 children recruited 
97 children with primary 
inclusion criteria 
83 children entering 
screening phase 
70 children with 
crossover trial inclusion 
criteria 
62 children begin 
crossover trial 
58 children finish 
crossover trial 
43 children without  
CPRS ADHD criteria 
14 children without 
neuropsychological ADHD 
criteria 
13 children did not finish 
screening phase:  
8 due to CGI improvement <50% 
5 due to compliance problems 
8 children did not enter 
crossover trial: 
5 refused participation in trial 
3 reached inclusion criteria > 
deadline 
4 children did not finish 
crossover trial: 
1 due to increasing tics 
2 due to behavior problems 
1 due to reactive depression 
4 children in RCT 
pilot trial 
group C 
group B 
group A Group D 
Group C 
 
Group B 
 
Group A 
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